National Center for Tumor Diseases (NCT) Heidelberg
Thomas N. Rösner is currently working as an Assistenzarzt at the National Center for Tumor Diseases (NCT) Heidelberg. Previously, Thomas N. was a Doctoral Researcher at Technische Universität München, focusing on cancer research related to pathway alterations during hepatic carcinogenesis. In addition, Thomas N. served as a scientific analyst in the biomarkers measurement team at FC Bayern München as a self-employed individual. Prior to that, Thomas N. completed a research internship in molecular neurophysiology at LMU - Ludwig-Maximilians-Universität München. Thomas holds a Doctor of Medicine (MD) degree from the Technical University of Munich and a First medical state examination in Medicine from Ludwig-Maximilians-Universität München.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.